Peptides for Cognition: What Users Report
Community reports on peptides used for cognitive enhancement — semax, selank, dihexa, noopept, and others. Anonymous accounts of focus, memory, mood, and neuroplasticity outcomes.
Cognitive enhancement is a smaller but rapidly growing category in community peptide data. The accounts here are distinct: they tend to come from users already familiar with the broader nootropics space who are exploring peptides specifically, and they focus on effects that are harder to measure than body composition — focus, verbal fluency, memory recall, anxiety, and mood. This page surfaces what those accounts describe.
Semax: the most documented cognitive peptide in community accounts
Semax is a synthetic ACTH(4–10) analogue registered in Russia; studies link it to BDNF signalling. It is not approved in Canada, the US or the EU. Reports describe sharper focus, verbal fluency and motivation, without a stimulant feel, and describe intranasal use. Reports also describe the effect fading with continuous use. No doses or schedules are published here.
Selank: anxiety and cognitive clarity
Selank is a tuftsin analogue registered in Russia as an anti-anxiety drug; it is not approved in Canada, the US or the EU. Reports describe less background anxiety and overthinking, framed as clearer thinking rather than enhancement, and contrast it with benzodiazepines (no sedation described). Evidence outside Russian studies is thin. No doses are published here.
BPC-157 and the gut-brain axis
Reports describing cognitive changes on BPC-157 are mostly from people using it for gut problems — less brain fog and better mood described alongside gut improvement. The gut–brain rationale is plausible but untested in humans. A small number of reports describe use after concussion; a head injury needs medical assessment.
NAD+ and cognitive energy
NAD+ accounts in the cognitive category describe energy and mental clarity rather than direct cognitive enhancement. The mechanism cited: NAD+ is a critical cofactor for mitochondrial function, and declining NAD+ levels with age are associated with reduced cellular energy in neurons. Accounts describe IV NAD+ as producing an acute cognitive clarity effect — described as a 'lifting of brain fog' that users attribute to rapid cellular energy restoration. Subcutaneous and intranasal NAD+ accounts describe less dramatic but more practical daily improvements in energy and mental sharpness. NAD+ stacks with epitalon appear in longevity-oriented cognitive accounts — the combination is described as targeting both cellular energy and circadian/pineal function simultaneously.
Combining cognitive peptides: what reports describe
Cognitive peptide accounts describe more careful cycling than any other category — the concern about receptor desensitisation and maintaining response is cited explicitly more often here than in body composition or recovery contexts. Semax and selank accounts describe cycling as essential rather than optional — accounts running either compound daily for extended periods describe declining response. The most common cognitive stack in community accounts: semax (focus, BDNF stimulation) + selank (anxiety reduction), described as complementary because they address different dimensions of cognitive performance without overlapping mechanisms. BPC-157 appears in cognitive stacks from users with gut-brain concerns; NAD+ appears in longevity-adjacent cognitive stacks. Accounts warn against starting multiple cognitive compounds simultaneously for the same reason given in all peptide stacking contexts: attribution of effects becomes impossible.
Related topics
Latest confessions
related peptides:
community guides:
More confessions from the archive
Community Q&A
- What peptides help with cognitive function?
- The most consistently documented cognitive peptides in community accounts: semax (focus, verbal fluency, BDNF stimulation — intranasal), selank (anxiety reduction enabling better cognitive performance — intranasal), BPC-157 (gut-brain axis, mood, brain fog — more pronounced in users with underlying gut issues), and NAD+ (cellular energy and mental clarity). Semax has the highest volume of direct cognitive benefit accounts. Selank accounts are more specifically anxiolytic than broadly cognitive.
- Does semax actually work?
- Reports on semax are fairly consistent about acute focus and verbal fluency, and less consistent about lasting effects. Several describe the effect fading with continuous use. The effect is described as a modest upgrade, not dramatic. Published evidence comes mainly from Russian clinical studies in stroke and cognitive disorders; it is not approved in Canada, the US or the EU.
- What is the difference between semax and selank?
- Community accounts describe them as complementary rather than equivalent. Semax is primarily described as cognitively stimulating — enhanced focus, verbal fluency, drive, and BDNF-mediated effects. Selank is primarily described as anxiolytic — reduced background anxiety enabling clearer thinking, better social performance, and improved working memory. Accounts that have tried both describe the combination as additive: semax for cognitive activation, selank for the anxiety that normally interferes with it. Neither compound is described as sedating in community accounts.
- Can BPC-157 help with brain fog?
- Reports describing less brain fog on BPC-157 mostly come from people whose gut symptoms improved at the same time; people without gut issues describe less effect. The link is plausible but untested in humans, and brain fog has many medical causes worth ruling out.
- How are semax and selank used?
- This site does not give doses or administration instructions for semax or selank. Reports almost always describe intranasal products, and describe the two used at different times for different goals — semax for focus, selank for anxiety. Neither is approved in Canada, the US or the EU.
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.